Moderna’s stock has been in the middle of its longest downturn in more than two years, having lost 50% of its value since August, when it hit a record high. The downturn in a few months has eliminated $ 98 billion in company capitalization. Although the Omicron mutation of the coronavirus is sweeping the globe, […]
Tag: Modern
Moderna: Starts developing a booster dose against Omicron in the coming weeks
The vaccine maker Moderna does not expect to have problems boosting a dose of its vaccine to protect against the Omicron mutation and is likely to start working on it within a few weeks, the CEO said in an interview. of the company, Stefan Bancell. Moderna hopes to begin clinical trials early this year to […]
Moderna: The third dose increases 37 times the neutralizing antibodies against Omicron
Moderna announced today that the booster dose of its Covid-19 vaccine appears in laboratory tests to protect against the rapidly transmitted Omicron variant and that the current version of the vaccine will continue to be Moderna’s “first line of defense against Omicron”. . The company announced that its decision to focus on the current vaccine, […]
Moderna: Does not apply for a patent for its vaccine
Moderna has dropped a patent application for a key part of its vaccine amid controversy with the US National Institutes of Health (NIH) over which scientists should be credited as its inventors, postponing a possible legal dispute between the company. and the government, Forbes reported. In 2020, Moderna applied for a patent for a genetic […]
EU: Agreement with Moderna to speed up the delivery of vaccines to Member States in need
The European Commission has reached an agreement with Moderna to speed up the delivery of its COVID-19 mRNA vaccine to EU Member States in short-term need, especially Germany. Moderna has agreed to deliver 10 million doses in December to Germany. These doses are equivalent to vaccinating 20 million people receiving a booster dose – as […]
How the fall of Moderna’s share ‘disappeared’ $ 100 billion
The stock Moderna fell sharply on Friday morning, after the announcement of the first results for its flu vaccine, which failed to impress investors. This development intensified a fall that “disappeared” almost 50% of the value of the share that showed one of the best performances this year. Because the encouraging results did not impress […]
Wells Fargo Prediction: Which company will dominate the Covid vaccine market?
Wells Fargo recently started “covering” Pfizer with a “buy” rating and a target price of $ 60 per share, indicating an upward trend of 16% from current levels. Wells Fargo analyst Mohit Bansal believes Pfizer’s anti-Covid treatments will generate significant revenue for the company in the “foreseeable future”, as new boosts will be needed to […]
Moderna: Develops ‘3 in 1’ vaccine against coronavirus, flu and RSV
An annual booster dose of the coronavirus vaccine, which will also provide protection against influenza and respiratory syncytial virus (RSV), has been announced by Moderna. The pharmaceutical company stressed that the “three in one” vaccine will be constantly modified for new mutations in the coronavirus. “A pillar of Moderna’s product strategy is the development of […]
Moderna: Shares fall despite encouraging results for flu vaccine
LAST UPDATE: 23:20 Moderna closed lower at 5.57% on Friday, following data from a study showing that the company ‘s mRNA technology vaccine may not be strong enough to give it an advantage over those already approved. flu vaccines on the market, especially for the elderly. The company announced in a presentation to investors that […]
Moderna vs Pfizer vaccines ‘scored 1’ in first major efficacy comparison
All mRNA vaccines are very effective and provide significant protection, but those of Moderna appear to be slightly better than those of Pfizer / BioNTech, according to the first direct comparison of their effectiveness made by American scientists. The comparison was based on an analysis of the electronic medical records of nearly 450,000 people who […]